NATCO Pharma Limited header image

NATCO Pharma Limited

524816

Equity

ISIN INE987B01026 / Valor 30461955

Bombay Stock Exchange Ltd. (Mumbai) (2026-10-05)

INR 822.15+0.05%

NATCO Pharma Limited
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Natco Pharma Limited is an Indian specialty pharmaceutical company headquartered in Hyderabad that develops, manufactures and markets generic formulations and active pharmaceutical ingredients, with a commercial emphasis on oncology and hepatology therapies. The company sells branded generics in the domestic market and exports products to regulated and emerging markets, pursuing regulatory filings and partnerships to enter markets such as the United States and Europe, while also undertaking contract manufacturing and licensing arrangements. Natco maintains in-house research and development capabilities focused on small-molecule development and formulation, supporting its product pipeline and manufacturing operations, and operates as a publicly listed player in India’s pharmaceutical sector.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-0.12%1Y

-5.04%3Y

-8.43%5Y

Performance

37.2%1Y

37.8%3Y

34.1%5Y

Volatility

1540 M

Market cap (USD)

39,263

Daily traded volume (Shares)

/

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited Valor: 11500585

Annual Return

-50%0%+50%

Risk level

110

1.98%INR 831.15

IQVIA Holdings Inc

IQVIA Holdings Inc Valor: 39103858

Annual Return

-50%0%+50%

Risk level

110

-2.30%USD 259.98

Apollo Hospitals Enterprise Limited

Apollo Hospitals Enterprise Limited Valor: 11650098

Annual Return

-50%0%+50%

Risk level

110

-1.31%INR 8,010.00

Envista Holdings Corporation

Envista Holdings Corporation Valor: 49153522

Annual Return

-50%0%+50%

Risk level

110

-0.30%USD 23.27

Humana Inc

Humana Inc Valor: 940174

Annual Return

-50%0%+50%

Risk level

110

0.05%USD 404.27

Park Medi World Limited

Park Medi World Limited Valor: 151471684

Annual Return

-50%0%+50%

Risk level

110

-2.00%INR 265.10

GSK PLC

GSK PLC Valor: 120042705

Annual Return

-50%0%+50%

Risk level

110

0.11%USD 46.60

Smith & Nephew PLC

Smith & Nephew PLC Valor: 1103058

Annual Return

-50%0%+50%

Risk level

110

0.70%GBP 10.12

Allogene Therapeutics Inc

Allogene Therapeutics Inc Valor: 43756548

Annual Return

-50%0%+50%

Risk level

110

-2.67%USD 1.46

Attendo AB

Attendo AB Valor: 30491576

Annual Return

-50%0%+50%

Risk level

110

-1.34%SEK 125.60

SIX

FactSet

Clearbit

Logos provided by Clearbit